ITPP + SR-9011 Tablets

ITPP + SR-9011 Tablets ITPP + SR-9011 tablets are researched in lab settings for their potential to regulate different pathways. Researchers use this stack to explore its possible effects on stamina, endurance, cellular energy, and metabolism in different research settings. Formulation Details: Each tablet contains 50 mg ITPP + 20 mg SR-9011 (Total: 70 mg per tablet) Available Counts: 27 tablets (1890 mg total) 54 tablets (3780 mg total) Overview of ITPP Tablets ITPP, also known as Myo-Inositol Trispyrophosphate, is a synthetic allosteric effector of hemoglobin. In different research models, ITPP has been shown to increase oxygen release from red blood cells. By doing so, ITPP may help oxygen delivery to tissues under hypoxic conditions (low oxygen). Preliminary studies have shown that by doing this, the compound may improve endurance, delay fatigue, and support cardiovascular function. Researchers have also explored its possible role in ischemia or tumor hypoxia, though findings remain limited. So more research is required! Overview of SR-9011 Tablets SR-9011 is structurally related to SR-9009 and belongs to the class of Rev-Erb agonists. Experimental studies have observed that SR-9011 may influence glucose metabolism, increase energy expenditure, and reduce fat accumulation in lab settings. Working Mechanism of ITPP + SR-9011 Tablets Both ITPP and SR-9011 work differently under various research environments. Here is the breakdown of their working mechanism: ITPP Tablets Researchers have observed that ITPP may work by modulating hemoglobin. Hemoglobin is believed to increase oxygen release from red blood cells in various research models. In research settings, it may alter the structure of hemoglobin to ease the delivery of oxygen smoothly in low-oxygen tissues. Studies suggest ITPP may also support cellular metabolism as observed in research subjects. The process is carried out when ITPP optimizes oxygen-dependent energy pathways in experimental models. Myo-inositol Trispyrophosphate (ITPP) CAS Number 23103-35-7 Molar Mass 605.98 g/mol Chemical Formula C6H12O21P6 IUPAC Name [[(2R,3R,4R,5R)-6-(dihydrogen phosphate)-3,4,5-trihydroxyoxan-2-yl]methyl] bis(dihydrogen diphosphate) SR-9011 Tablets Researchers have found from lab studies that SR-9011 may work by binding to Rev-Erb receptors in cells. A Rev-Erb agonist is a compound that may activate a nuclear receptor known as Rev-Erbα. The Rev-Erbα receptor protein is found in the cells, as studied in different research subjects. The binding may trigger the receptor, which then represses certain genes as observed in preclinical models. These genes are believed to control the production of proteins involved in metabolism and sleep-wake cycles in research subjects. SR 9011 CAS Number 1379686-29-9 Molar Mass 479.04 g/mol Chemical Formula C23H31ClN4O3S IUPAC Name 3-[[(4-chlorophenyl)methyl-[(5-nitrothiophen-2-yl)methyl]amino]methyl]-N-pentylpyrrolidine-1-carboxamide Combined Effects of ITPP + SR-9011 Tablets Researchers have closely observed in different laboratory settings that the combination of ITPP and SR-9011 may possess synergistic effects. These effects have been shown to potentially improve cellular energy, boost metabolic rate, and energy utilization in research subjects. Potential Benefits | ITPP Here are the potential benefits of ITPP as shown in preclinical models. These benefits are studied in various research settings and not in humans. Improves oxygen delivery to tissues in research subjects. Enhances endurance and exercise performance in research models. Increases oxygen utilization efficiency in research subjects. Supports muscle energy metabolism in research models. May reduce fatigue in research subjects. Improves hypoxia tolerance in research models. Potential Side Effects | ITPP The following are a few side effects observed in research subjects. However, long-term research is required to understand the full safety profile of this compound. Risk of altered oxygen saturation in research models. Potential electrolyte imbalance in research models. Risk of increased oxidative stress in research subjects. Possible mild gastrointestinal discomfort in research models. Potential Benefits | SR-9011 Below are the potential benefits of SR-9011 as shown in preclinical models. These benefits are studied in various research settings and not in humans. May enhance endurance in experimental models May increase metabolic rate in lab studies May improve lipid and glucose metabolism in experimental models May regulate circadian rhythm in preliminary studies May have anti-obesity effects in experimental models May optimize cellular energy in experimental models Potential Side Effects | SR-9011 The following are the side effects observed in research subjects. However, long-term research is required to understand the full safety profile of this compound. May disrupt sleep patterns in experimental models May cause fatigue in experimental models May affect appetite regulation in preliminary studies May induce mild liver enzyme changes in experimental models May increase heart rate in experimental models Where to Buy the ITPP + SR-9011 Tablets? You can buy ITPP + SR-9011 tablets directly from our online shop. At Purerawz, we offer you reliable and authentic ITPP + SR-9011 for research purposes. We also have a certificate of analysis (COA) of these compounds. Plus, the compounds are third-party verified. All these things ensure you have a safe experience. FAQs What is the half-life of ITPP + SR-9011 in research studies? The half-life of ITPP and SR-9011 varies by experimental model, but preliminary studies in lab settings suggest ITPP may remain active for a few hours. SR-9011 shows activity up to several hours, depending on metabolic conditions in research models. How stable is the ITPP + SR-9011 combination? In research models, the stack demonstrates good chemical stability under controlled lab conditions. However, its stability can be influenced by temperature, light exposure, and formulation methods used in tablet research. Why is the tablet form of ITPP + SR-9011 under research? Tablet form is being studied to optimize controlled absorption, improve dosage accuracy, and enhance convenience for experimental models. What is the shelf life and degradation pattern of ITPP + SR-9011? Experimental studies suggest that when stored in a dry, cool environment, the stack maintains potency for several months. Its degradation may occur faster under high humidity or heat, and research is ongoing to define the exact shelf life under various conditions. Disclaimer: This information is for educational purposes only and not medical advice. Products are for research use only. Research must follow IRB or IACUC guidelines. Verify information independently before purchasing. By ordering, you agree to our Terms and Conditions . If you are not 100% satisfied with the product you received, please contact us at support@purerawz.co ATTENTION: All our products are for LABORATORY AND RESEARCH PURPOSES ONLY, not for veterinary or human use.